Diabetes Mellitus: all 11,090 studies

Page 23 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.

• Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to PioglitazoneCompletedNCT02098746Results posted
• Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes MellitusCompletedNCT02098733Results posted
• The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 DiabetesCompletedNCT02098395Phase 3Results posted
• Impact of Structured Physical Activity Education Delivery in Patients With Type 2 Diabetes MellitusCompletedNCT02093702Not applicableResults posted
• Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes MellitusTerminatedNCT02093221Phase 2Results posted
• A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusCompletedNCT02091362Phase 2Results posted
• Intervention to Promote Weight Loss in Latinas At-risk for DiabetesCompletedNCT02088034Phase 4Results posted
• Effectiveness and Safety Study of the Dexcom G4 Platinum With Modified AlgorithmCompletedNCT02087995Not applicableResults posted
• An Evaluation of a Novel Glucose Sensing Technology in Type 2 DiabetesCompletedNCT02082184Not applicableResults posted
• mHealth Skill Enhancement Plus Phone CBT for Type 2 Diabetes Distress Medication Nonadherence: Pilot StudyCompletedNCT02081586Not applicableResults posted
• Brief CBT Interventions Delivered by Nurse Care Managers to Improve Type 2 Diabetes Outcomes: Pilot StudyCompletedNCT02081573Not applicableResults posted
• A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCompletedNCT02079805Phase 4Results posted
• A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT02072096Phase 4Results posted
• Framingham State Food StudyCompletedNCT02068885Not applicableResults posted
• Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic NephropathyCompletedNCT02065791Phase 3Results posted
• ADA Linagliptin in Long Term CareCompletedNCT02061969Phase 4Results posted
• The Safety and Efficacy of MK-1293 Versus Lantus™ in Participants With Type 2 Diabetes Mellitus (MK-1293-006)CompletedNCT02059187Phase 3Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)CompletedNCT02059174Phase 1Results posted
• A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)CompletedNCT02059161Phase 3Results posted
• Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCompletedNCT02058160Phase 3Results posted
• Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 DiabetesCompletedNCT02054897Phase 3Results posted
• Advanced Bolus Calculator for Type 1 Diabetes (ABC4D)CompletedNCT02053051Not applicableResults posted
• Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCompletedNCT02049814Phase 4Results posted
• Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise ProtocolCompletedNCT02047643Not applicableResults posted
• Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes MellitusCompletedNCT02046395Phase 4Results posted
• Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes MellitusTerminatedNCT02044848Phase 2Results posted
• A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 DiabetesCompletedNCT02038764Phase 1Results posted
• Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)CompletedNCT02036515Phase 3Results posted
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 DiabetesCompletedNCT02034513Phase 3Results posted
• A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).CompletedNCT02033889Phase 3Results posted
• Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on MetforminCompletedNCT02033876Phase 2Results posted
• Three Approaches to Glucose Monitoring in Non-insulin Treated DiabetesCompletedNCT02033499Not applicableResults posted
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 DiabetesCompletedNCT02030600Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and SitagliptinCompletedNCT02025907Phase 4Results posted
• Special Drug Use Surveillance of Pioglitazone/Metformin Hydrochloride Combination Tablets Survey on Long-term Use for Type 2 Diabetes MellitusCompletedNCT02024971Results posted
• Tailored Diabetes Self-Management ResourcesCompletedNCT02024750Not applicableResults posted
• Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetesCompletedNCT02023918Phase 2Results posted
• INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) StudyCompletedNCT02022111Not applicableResults posted
• A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 DiabetesTerminatedNCT02020616Phase 1/2Results posted
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsCompletedNCT02019264Phase 4Results posted
• Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 DiabetesCompletedNCT02014740Phase 4Results posted
• Mood and Diabetes Empowerment & Improvement TrainingCompletedNCT02010684Not applicableResults posted
• Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and AlbuminuriaCompletedNCT02010242Phase 2Results posted
• The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 DiabetesCompletedNCT02008682Phase 4Results posted
• A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)CompletedNCT02004886Phase 2Results posted
• Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient DataCompletedNCT02003898Not applicableResults posted
• Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"CompletedNCT02002975Results posted
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM PatientsCompletedNCT02002221Phase 4Results posted
• Morbidity in Newly Diagnosed type2 Diabetes in AdultsCompletedNCT02002091Results posted
• Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus PatientsCompletedNCT02000817Phase 1/2Results posted
• A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 DiabetesCompletedNCT01999322Phase 3Results posted
• Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)CompletedNCT01999218Phase 3Results posted
• Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 DiabetesCompletedNCT01997411Phase 2/3Results posted
• The Effect of Dietary Fiber-enriched Cereals on Glycemic Control and Secretion of Gut HormonesCompletedNCT01997281Not applicableResults posted
• Use of iPro™2 in Real Life Diabetes Management of Type 2 Patients in IndiaCompletedNCT01995539Not applicableResults posted
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusCompletedNCT01991795Phase 3Results posted
• User Evaluation of the MiniMed 640G Insulin PumpCompletedNCT01991548Not applicableResults posted
• Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.CompletedNCT01991197Phase 2Results posted
• Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes MellitusCompletedNCT01990300Results posted
• CareLink Connect - Technical Evaluation StudyCompletedNCT01989975Results posted
• A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusCompletedNCT01989754Phase 4Results posted
• Cardiovascular Outcomes Following Ertugliflozin Treatment in Type 2 Diabetes Mellitus Participants With Vascular Disease, The VERTIS CV Study (MK-8835-004)CompletedNCT01986881Phase 3Results posted
• A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)CompletedNCT01986855Phase 3Results posted
• Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)CompletedNCT01982630Phase 1Results posted
• The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 DiabetesCompletedNCT01980524Phase 2/3Results posted
• Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic PatientsCompletedNCT01975935Phase 2Results posted
• Jump Start Shared Medical Appointments for Diabetes With Weight ManagementCompletedNCT01973972Not applicableResults posted
• Diabetes Assistant (DiAs) Control-to-Range (CTR) Nocturnal Closed-Loop Camp StudyCompletedNCT01973413Not applicableResults posted
• Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 DiabetesCompletedNCT01973231Phase 4Results posted
• Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyCompletedNCT01972724Phase 4Results posted
• Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003)CompletedNCT01971554Phase 1Results posted
• Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac SurgeryTerminatedNCT01970462Phase 4Results posted
• Inpatient Diabetes on CorticosteroidsCompletedNCT01970241Phase 4Results posted
• Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 DaysCompletedNCT01969747Phase 2Results posted
• The Effect of Linagliptin on Mitochondrial and Endothelial FunctionCompletedNCT01969084Phase 4Results posted
• The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyCompletedNCT01966978Phase 4Results posted
• Advancing the Standard of Care for Pin Site CareCompletedNCT01965665Not applicableResults posted
• Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With BiguanidesCompletedNCT01964976Results posted
• Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes MellitusCompletedNCT01964963Results posted
• Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With SulfonylureaCompletedNCT01964950Results posted
• Comparison of Insulin Therapy in Treating Post-Transplant DiabetesTerminatedNCT01963728Phase 4Results posted
• A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular EventsCompletedNCT01959529Phase 3Results posted
• Evaluate the Immunogenicity of a Novel Glucagon FormulationCompletedNCT01959334Phase 3Results posted
• A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)CompletedNCT01958671Phase 3Results posted
• SMBG Protocols Predicting Glucose Levels in Senior Diabetes Mellitus With CADCompletedNCT01954771Not applicableResults posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusCompletedNCT01952145Phase 3Results posted
• Effect of Exenatide on Liver and Heart Fat and InflammationCompletedNCT01951651Phase 4Results posted
• Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 DiabetesCompletedNCT01951339Not applicableResults posted
• Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)CompletedNCT01948986Phase 1Results posted
• Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01947855Phase 3Results posted
• Harnessing mHealth and Social Support to Improve Diabetes Related Health Behavior for Inner-city PatientsCompletedNCT01945996Not applicableResults posted
• Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Combination Therapy With Thiazolidinediones"CompletedNCT01945242Results posted
• Alogliptin Tablets Special Drug Use Surveillance "Type 2 Diabetes Mellitus: Monotherapy/Combination Therapy With α-GI"CompletedNCT01945216Results posted
• Vitamin D and Type 2 Diabetes StudyCompletedNCT01942694Not applicableResults posted
• Enhancing Diabetic Foot Education by Viewing Personal Plantar PressuresCompletedNCT01941719Not applicableResults posted
• Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive AgentsCompletedNCT01939496Phase 4Results posted
• Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 DiabetesCompletedNCT01933672Phase 1Results posted
• Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesCompletedNCT01930188Phase 3Results posted
• Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 in Type 2 Diabetes Patients Taking MetforminCompletedNCT01929863Phase 2Results posted
• A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I DiabetesCompletedNCT01928329Phase 2Results posted

← Diabetes Mellitus overview